Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Weeks three through six often bring the first noticeable changes
At 12 months, there were no statistically significant differences between groups initially assigned to placebo or to treatment
The trial validates an oral maintenance strategy following successful injectable-led weight loss, promises to improve patient convenience and adherence through a simple daily pill, and does so with a reassuring safety profile
Shop Now / Sku: 730060 L-carnitine has been shown to stimulate the use of fat for fuel and boost metabolism, making it essential to energy generation in the body
MET-233i, a monthly dosing, ultra-long acting, subcutaneously injectable amylin analog candidate being evaluated as monotherapy and in combination with MET-097i in a Phase I trial
US$ 27.18
US$ 28.37
US$ 22.00
US$ 23.19
US$ 25.29
